ActiTrexx GmbH

Manufacturer, Biotechnology, Mainz, Germany

Mission & Vision: ATreg – For a life without Transplant Rejection. Graft-versus-Host-Disease (GvHD) is a common complication of stem cell transplantation that is associated with high morbidity and mortality. Our goal is to prevent the development of GvHD at an early stage with the cellular ...

Alder Therapeutics

Manufacturer, Biotechnology, Solna, Sweden

Alder Therapeutics is a virtual preclinical stem cell therapy development company that is shaping the future of regenerative medicine. Founded in 2022 by three seasoned cell therapy and industry experts, the company has two promising allogeneic stem cell therapy programs in the pipeline: one for ...

Astraveus SAS

Manufacturer, Biotechnology, Paris, France

Astraveus is developing the next generation of cell and gene therapy (CGT) manufacturing solutions. Astraveus's cell foundries miniaturize and automate cell and gene therapy manufacturing in a unique, modular, end-to-end, microfluidic solution that mimics the elegance of natural systems. The deep ...

BlueRock Therapeutics

Service, Pharma, New York, USA

Broken String Biosciences Ltd

Manufacturer, Biotechnology, Cambridge, United Kingdom

Broken String Biosciences is a genomics company with the goal of developing safer cell and gene therapies by assessing the stability of the genome. The Company is building a technology platform pipeline that will drive the development of cell and gene therapies that are safer by design. Its core ...

Cellino Biotech, Inc.

Manufacturer, Biotechnology, Cambridge, USA

Cellino is on a mission to make personalized, autologous cell therapies accessible for patients. Stem cell-derived regenerative medicines are poised to cure some of the toughest diseases within this decade, including Parkinson’s, diabetes, and heart disease. Patient-specific cells provide the ...

Cellusion Inc.

Service, Biotechnology, Tokyo, Japan

Cellusion is a regenerative medicine startup born from the Department of Ophthalmology, Keio University School of Medicine in 2015. Cellusion aims to contribute to the improvement of health and well-being around the world by solving unmet medical needs in medicine with its cutting-edge cell ...

Cimeio Therapeutics AG

Service, Biotechnology, Basel, Switzerland

We are an applied gene editing, cellular, and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs™ for patients with debilitating and life-threatening diseases. Our proprietary technology platform is based on the discovery of novel protein variants, which when ...

Histide AG

Manufacturer, Diagnostics, Schindellegi, Switzerland

Histide™ is pioneering Recoding Therapeutics™, a novel therapy using non-mutagenic extracellular technologies to direct cell fate. Based on the universal understanding of the mechanisms underlying mammalian cell behavior, Histide™ has created an innovative platform of complex microenvironments ...

Inceptor Bio

Service, Biotechnology, Morrisville, USA

Inceptor Bio is a biotechnology company developing multiple next-generation cell therapy products to deliver cures for underserved and difficult-to-treat cancers. Inceptor Bio is developing CAR-T, CAR-M, and CAR-NK platforms to generate a diversified pipeline to strategically treat a broad range ...